Healthcare stocks are slightly higher, with the NYSE Healthcare
Sector Index adding about 0.1% and shares of healthcare companies
in the S&P 500 rising about 0.1% as a group.
In company news, Illumina Inc. (
) shares advanced after the diagnostics company announced a
collaboration pact with Amgen Inc. (
) to develop and commercialize a multigene, NGS-based test as a
companion diagnostic for Vectibix to treat metastatic colorectal
ILMN was up 3.1% at $124.89 a share in recent trading, after
earlier hitting a new, 52-week high at $127. AMGN shares were up
0.2% at $118.80 this afternoon.
Vectibix previously was approved in the U.S. and EU. Under the
terms of the agreement, the companies will develop the test to work
with ILMN's MiSeqDx testing device, which last year received
pre-market clearance from the FDA and was also CE-marked for use in
the European Union.
In other sector news,
(+) SRPT, (+42.8%) Said its Eteplirsen drug candidate continues
to show stabilization of walking ability during six-minute walking
test and no adverse reactions in patients with Duchenne muscular
dystrophy through 120 weeks of Phase IIb testing.
(-) AMRN, (-6.5%) Said the FDA's Division of Metabolism and
Endocrinology Products told the company it was delaying a decision
on the drug-maker's request to reinstate special protocol
assessment for testing expanded uses of its anti-cholesterol